<DOC>
	<DOC>NCT02932995</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of a novel dual drug-eluting stent (DXR stent), which slowly releases both cilostazol and paclitaxel, for strut coverage, malapposition, and thrombus formation, assessed by an optical coherence tomography.</brief_summary>
	<brief_title>DXR Stent for Vascular Healing and Thrombus Formation: OCT Study</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1. Patient Age &gt;=19 years Clinically indicated to invasive coronary angiography Patient capable and willing of giving written informed consent 2. Angiographic coronary artery disease confined to native coronary artery &gt;50% diameter stenosis by invasive coronary angiography reference diameter 2.54.0mm, lesion length â‰¤30 mm 1. Patient Inability to provide written informed consent Serious comorbidity which may affect the trial by decision of investigators Prior CABG to target vessel Congestive heart failure with NYHA Class III or IV or left ventricular ejection fraction less than 30% Prior ST elevation myocardial infarction within 72 hours from the procedure Hemodynamic or electrical instability including shock Serious coronary artery spasm, unrelated to catheter Pregnancy or possible pregnant status Allergy to iodinated contrast agent Serum creatinine &gt;=1.7 mg/dL or creatinine clearance &lt;= 30 ml/min ST elevation myocardial infarction 2. Angiographic (OCT) Left main disease Severely calcified lesion Severely tortuous, or TIMI flow grade 0 or 1 by angiography, or inappropriate for OCT procedure by investigators' decision</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Optical Coherence Tomography</keyword>
	<keyword>Drug-Eluting Stent</keyword>
</DOC>